TAGLN has also been identified as a fibroblast-specific biomarker of poor prognosis in colorectal cancer (CRC) in a single-cell multiomics sequencing study, with 21 patients with CRC and 6 cancer-free individuals [24]. The gene discussed is TAGLN; the disease is cancer.